Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2026)
Kestra Medical Technologies (KMTS) reported Cash from Financing Activities of $149.2 million for Q1 2026, up 125463.03% year-over-year from N/an in Q1 2025, and up 552625.93% quarter-over-quarter from -$27000.0 in Q4 2025.
Kestra Medical Technologies (KMTS) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has 3 years of Cash from Financing Activities data on file, last reported at $149.2 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $149.2 million, up 125463.03% year-over-year; the trailing twelve-month figure through Jan 2026 was $362.0 million (up 183.25% YoY), and the FY2025 annual result was $330.3 million, up 324.91% from the prior year.
- Cash from Financing Activities rose to $149.2 million in Q1 2026 per KMTS's latest filing, from -$27000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $214.7 million in Q2 2025 and troughed at -$1.9 million in Q3 2025.
- A 3-year average of $61.2 million and a median of $6.1 million in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 101.61% in 2025, then jumped 125463.03% in 2026.
- A 3-year view of Cash from Financing Activities shows it stood at -$575000.0 in 2024, then surged by 95.3% to -$27000.0 in 2025, then jumped by 552625.93% to $149.2 million in 2026.
- Business Quant data shows KMTS's Cash from Financing Activities at $149.2 million in Q1 2026, -$27000.0 in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Kestra Medical Technologies | 1.02 Bn | 732.25 Mn | 12.91 Mn | 149.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 149.18 Mn |
| Jan 31, 2026 | 149.18 Mn |
| Oct 31, 2025 | -27,000.00 |
| Oct 31, 2025 | -27,000.00 |
| Jul 31, 2025 | -1.88 Mn |
| Jul 31, 2025 | -1.88 Mn |
| Apr 30, 2025 | 214.70 Mn |
| Apr 30, 2025 | 214.70 Mn |
| Jan 31, 2025 | -119,000.00 |
| Jan 31, 2025 | -119,000.00 |
| Oct 31, 2024 | -575,000.00 |
| Oct 31, 2024 | -575,000.00 |
| Jul 31, 2024 | 116.25 Mn |
| Jul 31, 2024 | 116.25 Mn |
| Apr 30, 2024 | 12.24 Mn |
| Apr 30, 2024 | 12.24 Mn |